Massive infectious soft-tissue injury: Diagnosis and management of necrotizing fasciitis and purpura fulminans

Plastic and Reconstructive Surgery

Volumn 107, Issue 4, 2001, Pages 1025-1035

  Andreasen, Troy J ^a,b   Green, Scott D ^a,b   Childers, Ben J ^a,b  

^a Loma Linda University Medical Center ^*

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CLINDAMYCIN; PENICILLIN G;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL SKIN; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FROZEN SECTION; FULMINATING PURPURA; HUMAN; MALE; NECROTIZING FASCIITIS; PRIORITY JOURNAL; SKIN GRAFT; SOFT TISSUE INFECTION; SOFT TISSUE INJURY;

EID: 0035313438     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200104010-00019     Document Type: Article

References (76)

1. Treatment of skin and soft-tissue infections
2. Anaerobes from a surgical perspective
3. The role of surgery in the management of uncommon skin infections
4. Drug treatment of skin and soft tissue infections in elderly long-term care residents
5. Microbial factors in disease emergence illustrated by streptococcal toxic shock syndrome
6. The toxins of group A streptococcus, the flesh eating bacteria
7. Necrotizing soft-tissue infections
8. Streptococcal toxic shock-like syndrome
9. Soft tissue infections and the diabetic foot
10. Soft tissue infections
11. Outpatient parenteral antibiotic therapy: Management of serious infections, part II: Amenable infections and models for delivery: Cellulitis
12. Necoritizing fasciitis
13. The strept-A scare
14. Joseph Jones: Infections with flesh-eating bacteria
15. Hemolytic streptococcal gangrene: Importance of early diagnosis and early operation
16. IDCP guidelines: Necrotizing skin and soft tissue infections, part I: Necrotizing fasciitis
17. Determinants of mortality for necrotizing soft-tissue infections
18. Necrotizing fasciitis: A preventable disaster
19. Necrotizing fasciitis
20. Necrotizing fasciitis
21. Necrotizing fasciitis: A fourteen-year retrospective study of 163 consecutive patients
22. Streptococcal necrotizing fasciitis: Development of an animal model to study its pathogenesis
23. Necrotizing fasciitis and gangrene of the upper extremity
24. Nonsteroidal anti-inflammatory drugs and necrotizing fasciitis: An update
25. Invasive soft tissue infections with Streptococcus pneumoniae in patients with systemic lupus erythematosus: Case report and review of the literature
26. Group B streptococcal infection in older patients: Spectrum of disease and management strategies
27. Necrotizing soft-tissue infections
28. Necrotizing soft tissue infections of the chest wall
29. Soft tissue infections
30. Necrotizing soft-tissue infections
31. Management of staphylococcal and streptococcal infections
32. Improved results from a standardized approach in treating patients with necrotizing fasciitis
33. Early recognition of potentially fatal necrotizing fasciitis: The use of frozen-section biopsy
34. Effect of the factor V Leiden mutation on the severity of meningococcal disease
35. Integra artificial skin as a useful adjunct in the treatment of purpura fulminans
36. Management of cutaneous manifestations of extensive purpura fulminans in a burn unit
37. Purpura fulminans
38. Purpura fulminans
39. Purpura fulminans and transient protein C and S deficiency
40. Purpura fulminans: A disease best managed in a burn center
41. Coumarin necrosis, neonatal purpura fulminans, and protein C deficiency
42. Neonatal purpura fulminans due to homozygous protein C or S deficiencies
43. Acute infectious purpura fulminans: Pathogenesis and medical management
44. Management strategy in purpura fulminans with multiple organ failure in children
45. Protein C and protein S levels in two patients with acquired purpura fulminans
46. Haemophilus influenza type b purpura fulminans treated with hyperbaric oxygen
47. Purpura fulminans secondary to Xanthomonas maltophilia sepsis in an adult with aplastic anemia
48. Purpura fulminans localizing to a recent burn injury
49. Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli 055:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1 beta
50. Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus. Quantitative measurements and biological reactivities
51. Streptococcal toxic-shock syndrome: Spectrum of disease, pathogenesis, and new concepts in treatment
52. Antibiotic effects on bacterial viability, toxin production, and host response
53. Cervical necrotizing fasciitis
54. Hyperbaric oxygen therapy for necrotizing fasciitis reduces the need for debridements
55. Adjunctive hyperbaric oxygen therapy for necrotizing fasciitis: A 10-year experience
56. Hyperbaric oxygen in the treatment of life-threatening soft-tissue infections
57. Gas gangrene: Potential for hyperbaric oxygen therapy
58. The place for hyperbaric oxygen in the treatment of gas gangrene
59. Hyperbaric oxygen in the treatment of gas gangrene and perianal necrotizing fasciitis: A clinical and experimental study
60. Uses of hyperbaric oxygen therapy in the 1990s
61. Hyperbaric oxygen therapy in the pediatric patient: The experience of the Israel Naval Medical Institute
62. Purpura fulminans: Medical, surgical, and rehabilitative considerations
63. Topical nitroglycerin and pain in purpura fulminans
64. Compared contralateral application of topical nitroglycerin on purpura fulminans
65. Successful use of leeches in the treatment of purpura fulminans
66. The role of heparin in the prevention of extremity and digit necrosis in meningococcal purpura fulminans
67. Acquired purpura fulminans induced by alcohol and acetaminophen: Successful treatment with heparin and vitamin K
68. Meningococcal purpura fulminans treated with antithrombin III concentrate: What is the optimal replacement therapy?
69. Postpartum purpura fulminans: Successful management with streptokinase
70. Dextran therapy in purpura fulminans
71. Protein-C concentrate for meningococcal purpura fulminans
72. Protein C in the treatment of coagulopathy in meningococcal disease
73. Early diagnosis, nutritional support, and immediate extensive debridement improve survival in necrotizing fasciitis
74. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury